MRSA (methicillin-resistant staphylococcus aureus)

MRSA is presently a pathogen of global health concern. . They are S. aureus strains that are resistant to oxacillin, nafcillin and methicillin. They can also be resistant to all ß-lactam agents.  It can cause a variety of problems ranging from skin infections and sepsis to pneumonia and various types of bloodstream infections. The infections occur commonly among people in hospitals and healthcare facilities such as nursing homes, diagnostic centres and dialysis centres, who have less stable immune systems. The current arsenal of antibiotics available for the treatment of MRSA includes a topical agent, a limited number of oral agents.

 

  • Community-acquired MRSA (CA-MRSA)
  • Healthcare-associated MRSA (HA-MRSA)
  • Virulence Associated Factors of CA-MRSA
  • Antibiotic resistance
  • Recurrent MRSA Infections
  • Oral and intravenous agents
  • Topical agents
  • Vancomycin, Clindamycin and linezolid
  • Pneumonia (HAP/VAP)
  • Chronic osteomyelitis (COM)
  • Skin and soft tissue infections

Related Conference of MRSA (methicillin-resistant staphylococcus aureus)

October 24-25, 2022

17th World Congress on Virology, Emerging Diseases & Vaccines

Zurich, Switzerland
November 08-09, 2022

7th Rare Diseases and Orphan Drugs

London, UK
November 21-22, 2022

World Summit on Rare Disease

Rome, Italy
December 12-13, 2022

5th Pathology and Infectious Disease Conference

Prague, Czech Republic
January 23-24, 2023

10th International Congress on Infectious Diseases

Barcelona, Spain
February 20-21, 2023

6th International Conference on Rare Diseases

Amsterdam, Netherlands
August 08-09, 2023

19th World Congress on Infection Prevention and Control

Zurich, Switzerland
September 27-28, 2023

32nd International Conference on Coronary Diseases

Zurich, Switzerland

MRSA (methicillin-resistant staphylococcus aureus) Conference Speakers

Recommended Sessions

Related Journals

Are you interested in